BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/06/2025

FDA Classifies Cream for X-Ray Attenuation into Class II Special Controls

The FDA has classified the cream for x-ray attenuation into Class II special controls, aiming to provide a reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patients' access to innovative devices.

Source: Federal Register — Food and Drug AdministrationOpen original release →